Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.

Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer. Am J Clin Oncol. 2015 Oct; 38(5):442-7.

View in: PubMed

subject areas

Calcium
Carcinoma, Non-Small-Cell Lung
Endocrine Disruptors
Female
Humans
Hypogonadism
Insulin-Like Growth Factor I
Lung Neoplasms
Luteinizing Hormone
Male
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Pyrazoles
Pyridines
Receptor Protein-Tyrosine Kinases
Reference Values
Testosterone

authors with profiles

Ravi Salgia